Xijing Hospital
Xi'an, Shaanxi, 710032, China
NCT Number: NCT00778323
The purpose of this study is to assess whether a large clinical trial testing the effect of RIPC on neurologic outcome in patients undergoing elective cervical decompression surge is warranted.
Looking for future studies?
Notify Me30 year–75 year
All sexes
Interventional
Phase 1 / Phase 2
Xi'an, Shaanxi, 710032, China
Spinal cord ischemia-reperfusion injury commonly contribute to perioperative morbidity and mortality after elective cervical decompression surgery.Remote ischemic preconditioning(RIPC)is a phenomenon whereby brief periods of ischemia followed by reperfusion in one organ provide system protection from prolonged ischemia.The hypothesis of this protocol is that limb ischemic preconditioning could reduces spinal cord ischemia-reperfusion injury induced by elective cervical decompression surgery.Serum s-100B and NSE concentration will be measured before and after induction ,and at 6 hours,1,3,5 and 7days after surgery.JOA scores in all the cases will be evaluated before operation and at 7days ,1,3,6 month after surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
LRIPC consists of three 5-min cycles of right upper limb ischemia induced by an automated cuff-inflator placed on the upper arm and inflated to 200 mmHg,with an intervening 5 min reperfusion during which the cuff is deflated.
Other names: an automated cuff-inflator made in China
Time frame: 1 week or more
Time frame: 6 months
Xijing Hospital
Other
Effects of Remote Ischemic Preconditioning on Biochemical Markers and Neurological Outcomes in Patients Undergoing Elective Cervical Decompression Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04924985
Cardiovascular Diseases, Ischemia
New York, United States
View Trial DetailsNCT05459883
Cardiovascular Diseases, Hepatectomy
Athens, Attica, Greece
View Trial DetailsNCT00402506
Cardiovascular Diseases, Coronary Artery Bypass Graft Surgery
Durham, North Carolina, United States
View Trial DetailsNCT00157716
Cardiovascular Diseases, Coronary Artery Bypass Graft Surgery
Durham, North Carolina, United States
View Trial Details